Here, we address the barriers in integrating WGTS for cancer diagnostics and treatment selection and answer questions regarding utility in different cancer types, cost-effectiveness and affordability, ...
Comprehensive molecular profiling of advanced cancers in a real-world setting using an ultrasensitive amplicon-based next-generation sequencing (NGS) liquid biopsy assay. Improving differential ...
First PWAS for AD, now TWAS for PD. Hot on the heels of a study that linked AD variants to changes in a protein-wide association study (Feb 2021 news), geneticists now have linked Parkinson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback